GlobalData on MSN
AstraZeneca boosts US footprint with Texas site expansion
The $445m expansion is set to effectively double the production of Lokelma for the benefit of patients in the US and globally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback